Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

Author： Holmes A.   Heilig M.   Rupniak N.M.J.   Steckler T.   Griebel G.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.24, Iss.11, 2003-11, pp. : 580-588

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression

By Paschos Konstantinos A.  

CNS Drugs, Vol. 23, Iss. 9, 2009-09 ,pp. : 755-772

Adis International

Access to resources Recommend Favorite

Gut Emotions - Mechanisms of Action of Probiotics as Novel Therapeutic Targets for Depression and Anxiety Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 10, 2014-12 ,pp. : 1770-1786

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment

By  

Current Neuropharmacology, Vol. 12, Iss. 2, 2014-03 ,pp. : 108-119

Bentham Science Publishers

Access to resources Recommend Favorite

Galanin: A Novel Therapeutic Target for Depression, Anxiety Disorders and Drug Addiction?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 2, 2006-04 ,pp. : 225-232

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptides as Therapeutic Targets in Anxiety Disorders

By  

Current Pharmaceutical Design, Vol. 18, Iss. 35, 2012-12 ,pp. : 5709-5727

Bentham Science Publishers

Access to resources Recommend Favorite